poloxalene has been researched along with Glioblastoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| de Melo, MT; Paula, LB; Pellosi, DS; Tedesco, AC | 1 |
| Hussain, MD; Saxena, V | 1 |
2 other study(ies) available for poloxalene and Glioblastoma
| Article | Year |
|---|---|
Targeted and Synergic Glioblastoma Treatment: Multifunctional Nanoparticles Delivering Verteporfin as Adjuvant Therapy for Temozolomide Chemotherapy.
Topics: Animals; Brain Neoplasms; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Survival; Chemotherapy, Adjuvant; Drug Compounding; Drug Liberation; Drug Stability; Drug Synergism; Glioblastoma; Humans; Mice; Microscopy, Atomic Force; Microscopy, Confocal; Nanoparticles; NIH 3T3 Cells; Particle Size; Poloxalene; Rhodamines; Temozolomide; Verteporfin | 2019 |
Formulation and in vitro evaluation of 17-allyamino-17-demethoxygeldanamycin (17-AAG) loaded polymeric mixed micelles for glioblastoma multiforme.
Topics: Benzoquinones; Biological Transport, Active; Blood-Brain Barrier; Brain Neoplasms; Cell Line, Tumor; Cell Survival; Chemistry, Pharmaceutical; Drug Carriers; Drug Compounding; Drug Delivery Systems; Glioblastoma; HSP90 Heat-Shock Proteins; Humans; Lactams, Macrocyclic; Micelles; Nanocapsules; Particle Size; Poloxalene; Poloxamer | 2013 |